AI in Medicine News ・ 🩻 Diagnosis and imaging

FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment

Diagnostic Imaging · 10/20 15:09 UTC

The NEXT-Cue AI software incorporates analysis of brain MRI scans. It reportedly supports prognostic assessments of potential progression from mild cognitive impairment (MCI) to Alzheimer's disease within five years.

Read the original (Diagnostic Imaging)

See it in the digest → ・ See this issue →